|
A CCL8-based cytotoxic analog for cancer management
Reference #: 1721
The University of South Carolina is offering licensing opportunities for A CCL8-based cytotoxic analog for cancer management.
Background:
Deregulation of cytokine and chemokine networks is common in various malignancies and other pathologies and has causative role in disease progression. Despite however their acknowledged role in...
Published: 2/9/2026
|
Updated: 12/17/2024
|
Inventor(s): Hippokratis Kiaris, Bernardo Chavez
Keywords(s):
Category(s): Health Sciences, Biomedical and Life Sciences
|